Vanberra Signal

AgenT

Curated by Signal

Developer of AI-based blood diagnosis solutions to detect Alzheimer’s diseases

Overview

Developer of AI-based blood diagnosis solutions to detect Alzheimer’s diseases. The company has developed diagnostic tools that prevent patients from nerve damages. It combines machine learning and multi-omics biomarkers signals to detect Alzheimer's from the silent phase. It also helps to analyze protein and metabolites present in the blood plasma.

Key facts

Founded
2018
Headquarters
Paris, France

Business model

Contact

Open roles

1 role
  • 前端开发工程师

    Shanghai, Shanghai, China · On-site · Full-time

More on Vanberra Signal

Members only

Competitors & similar companies

More Life Sciences Technology companies
  • Developer of robotic medical equipment for skin cancer detection

    Life Sciences TechnologyParis, France
  • Provider of software tools to analyze next-gen sequencing data sets

    Life Sciences TechnologyRouen, France
  • Provider of machine learning based solutions for drug discovery and precision medicine

    Life Sciences TechnologyParis, France

About AgenT

What does AgenT do?

Developer of AI-based blood diagnosis solutions to detect Alzheimer’s diseases.

Where is AgenT headquartered?

AgenT is headquartered in Paris, France.

When was AgenT founded?

AgenT was founded in 2018.

Which sector is AgenT in?

AgenT operates in Life Sciences Technology.

Who are AgenT's competitors?

Companies similar to AgenT include SquareMind, Interactive biosoftware, and Owkin.

Is AgenT hiring?

Yes. AgenT has 1 open role listed on Vanberra Signal.